Situation normale

MAES PHARMCONSULT
 SRL

4600 Visé
Since 24/08/2005
BE0875845464
Financial Health Indicator
7
Equity
€157.3K
+3% YoY
Gross Operating Margin
€18.6K
-59% YoY
EBITDA
€18.6K
-59% YoY
Gain/Loss
€4.7K
-85% YoY

MAES PHARMCONSULT’s business network visualized

Explore our interactive spiderweb to visually navigate MAES PHARMCONSULT’s entire network of mandates and participations. Get insights into both current and historical connections.

Spiderweb MAES PHARMCONSULT
MAES PHARMCONSULT
  • Paul Maes
    4600 Visé
    Since 2005

Detailed insights into MAES PHARMCONSULT’s financial history

See financial trends including, equity, operating income, profit/loss and employees of MAES PHARMCONSULT. Compare KPI’s against similar companies. Explore financial ratios, annual accounts and much more.

Financials 1
Financials 2
Financials 3
Financials 4
2024 2023 2022 2021 2020
Equity
157.3K
152.6K
146.3K
127.9K
124.3K
Gross Operating Margin
18.6K
45.8K
42.0K
39.0K
48.5K
Gain/Loss
4.7K
30.6K
37.5K
26.0K
25.0K

Frequently asked questions about MAES PHARMCONSULT

  • Where is MAES PHARMCONSULT located?

    MAES PHARMCONSULT’s headquarters is located in Rue de Dalhem(VIS) 5 , 4600 Visé.
  • Who are the directors of MAES PHARMCONSULT?

    MAES PHARMCONSULT’s directors include
    • Paul Maes
  • When was MAES PHARMCONSULT founded?

    MAES PHARMCONSULT was founded in 2005-08-24. MAES PHARMCONSULT has been active for 20 years.
  • What are MAES PHARMCONSULT’s NACEBEL codes?

    MAES PHARMCONSULT’s NACEBEL codes are
    • 70220 Conseil pour les affaires et autres conseils de gestion (2008)
    • 74142 Autres conseils pour les affaires et le management (2003)
  • What is MAES PHARMCONSULT’s VAT number?

    MAES PHARMCONSULT’s VAT number is BE0875845464.
  • What is MAES PHARMCONSULT’s juridical form?

    MAES PHARMCONSULT’s juridical type is Société à responsabilité limitée (SRL).
  • How is the financial situation of MAES PHARMCONSULT?

    openthebox has estimated that MAES PHARMCONSULT’s financial health score to be 7/10.